Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 40

Sort by

Sort Order Select

Journal Articles

B-ALL/NHL 2002 GMALL Protocol As First-Line Treatment in Patients with Double-Hit Lymphoma: Favorable Results in18 Consecutive Patients from Two Italian Institutions

Safaa M. Ramadan, PhD MD, Alessandro Cignetti, MD PhD, Simona Sammassimo, MD, Enrico Derenzini, MD PhD, Giusy Ceparano, MD, Tommaso Radice, MD, Federica Gigli, MD, Stefano Fiori, MD, Valentina Tabanelli, MD, Martina Milani, Emanuela Omodeo Sale', Sara Gandini, PhD, Daniela Gottardi, MD, Giuseppe Saglio, MD, Stefano Pileri, MD, Corrado Tarella, MD

Blood (2019) 134 (Supplement_1): 1631.

https://doi.org/10.1182/blood-2019-128794

Published: 2019

Journal Articles

The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma

Blood (2019) 133 (9): 962–966.

https://doi.org/10.1182/blood-2018-07-864025

Published: 2019

Includes: Supplemental data

Journal Articles

Unusual presentation of Burkitt-like lymphoma with 11q aberration in an elderly patient

Habib Moshref Razavi, Monica Hrynchak

Blood (2019) 133 (4): 381.

https://doi.org/10.1182/blood-2018-08-864728

Published: 2019

Journal Articles

Infectious Complications and Mortality after Autologous Stem Cell Transplantation for Lymphomas: A Comparison Between HIV-Infected and HIV-Negative Patients

Juan Churruca, Mariana Bastos-Oreiro, Julia Suárez González, Carolina Martinez-Laperche, Pascual Balsalobre, Pilar Miralles, Juan Berenguer, David Serrano, MD, Mi Kwon, MD, Jorge Gayoso, MD, Jose Luis Diez-Martin, MD PhD

Blood (2016) 128 (22): 2258.

https://doi.org/10.1182/blood.V128.22.2258.2258

Published: 2016

Journal Articles

Veliparib (ABT-888), Bendamustine, and Rituximab (VBR) Is Well Tolerated and Efficacious in Patients with Lymphoma: Final Analysis of a Phase 1b Clinical Trial of VB and a Cohort Expansion of Vbr in Patients with B-Cell Lymphoma

Jacob D Soumerai, MD, Andrew D Zelenetz, MD PhD, Craig H Moskowitz, MD, Anas Younes, MD, Maria Lia Palomba, MD, Paul A Hamlin, Jr., MD, Ariela Noy, MD, Steven M Horwitz, MD, Matthew J. Matasar, MD MS, Alison J Moskowitz, MD, Carol S Portlock, MD, David J Straus, MD, Alice Chen, MD, Richard F Little, MDMPH, Fallon France, Juho Whang, Nishant Mishra, Christine Jarjies, John F Gerecitano, MD PhD

Blood (2015) 126 (23): 2691.

https://doi.org/10.1182/blood.V126.23.2691.2691

Published: 2015

Journal Articles

Outcomes of Primary and Secondary Transformed B-Cell Lymphomas

Sedat Demirdas, Lewin Eisele, MD, Jörg Hense, MD, Ulrich Dührsen, MD, Andreas Hüttmann, MD

Blood (2015) 126 (23): 3894.

https://doi.org/10.1182/blood.V126.23.3894.3894

Published: 2015

Journal Articles

Autologous Hematopoietic Stem Cell Transplantation (AHCT) in Patients with Chemotherapy-Sensitive, Relapsed/Refractory (CSRR) Human Immunodeficiency Virus (HIV)-Associated Lymphoma (HAL): Results from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0803)/AIDS Malignancy Consortium (AMC-071) Trial

J Alvarnas, MD, J Le Rademacher, PhD, Y Wang, M.S., Richard F. Little, MDMPH, G Akpek, MD MHS, FACP, E Ayala, MD, S Devine, MD, L Kaplan, MD, A Noy, MD, U Popat, MD, J Thompson, M.S., M H Horowitz, MD MS, A Mendizabal, PhD, W H. Navarro, MD, R Ambinder, MD PhD, Blood and Marrow Transplant Clinical Trials Network (BMT CTN), The AIDS Malignancy Consortium (AMC)

Blood (2014) 124 (21): 674.

https://doi.org/10.1182/blood.V124.21.674.674

Published: 2014

Journal Articles

Differentiating Burkitt Lymphoma from Burkitt-like Lymphoma in Pediatrics: Report from the Japanese Pediatric Leukemia/Lymphoma Study Group B-NHL03 Study

Blood (2014) 124 (21): 1651.

https://doi.org/10.1182/blood.V124.21.1651.1651

Published: 2014

Journal Articles

Consolidative Radioimmunotherapy after Chemoimmunotherapy in Patients with Histologic Transformation of Indolent Lymphoma

Patrick M. Reagan, MD, Jennifer L. Kelly, PhD MPH, Andrea Baran, MS, Paul M. Barr, MD, Carla Casulo, MD, Vaseem Chengazi, MD PhD, Jonathan W. Friedberg, MD MMSc

Blood (2014) 124 (21): 1746.

https://doi.org/10.1182/blood.V124.21.1746.1746

Published: 2014

Journal Articles

Lymphomas With MYC -Translocation Other Than Burkitt’s Have An Aggressive Presentation and Poor Response To Immunochemotherapy: Study Of 34 Cases

Jose-Tomas Navarro, MD, PhD, Maria Joao Baptista, PhD, Alejandra Martinez-Trillos, MD, Gustavo Tapia, MD, Jose Angel Hernandez-Rivas, MD, PhD, Olga Garcia, Anna Muñoz-Marmol, PhD, Juan-Manuel Sancho, MD, PhD, Fuensanta Millá, MD, PhD, Evarist Feliu, MD, PhD, Jose-Luis Mate, MD, PhD, Armando Lopez-Guillermo, MD, PhD, Josep-Maria Ribera, MD, PhD

Blood (2013) 122 (21): 5083.

https://doi.org/10.1182/blood.V122.21.5083.5083

Published: 2013

Journal Articles

Rituximab Improves Overall Survival In Patients Treated With CODOX-M/IVAC For Burkitt Lymphoma (BL) and B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and BL: A Single Center Experience and Review Of The Literature

Anca Prica, MD, Ariella Pratzer, Matthew C Cheung, MD, Kim Thompson, Eugenia Piliotis, MD, Neil L Berinstein, MD, Kevin R. Imrie, MD, Rahim Pradhan, Anju Vyas, David Good, MD, Liying Zhang, PhD, Rena Buckstein, MD

Blood (2013) 122 (21): 5093.

https://doi.org/10.1182/blood.V122.21.5093.5093

Published: 2013

Journal Articles

Diffuse Large B Cell Lymphoma: Role Of MYC, BCL2, BCL6 Protein Expressions and Translocations

Susmita Sakruti, MD, Nabila Bennani, MD, Swapna Thota, MD, Rohan Garje, MD, Adewale Fawole, MD, Paul Elson, ScD, Abdo Haddad, MD, Timothy Spiro, M.D., Hamed Daw, M.D.

Blood (2013) 122 (21): 5055.

https://doi.org/10.1182/blood.V122.21.5055.5055

Published: 2013

Journal Articles

Lenalidomide In Combination With R-ESHAP (LR-ESHAP) In Patients With Relapsed Or Refractory Diffuse Large B-Cell Lymphoma Candidates To Autologous Stem-Cell Transplantation: A Phase 1b Study From Spanish Group Geltamo

Alejandro Martín, Alba María Redondo, Armando López-Guillermo, Antonio Salar, MD, Eva González-Barca, Miguel Canales, Dolores Caballero, MD, PhD

Blood (2013) 122 (21): 4391.

https://doi.org/10.1182/blood.V122.21.4391.4391

Published: 2013

Journal Articles

Autologous Stem Cell Transplantation For Adult Burkitt Lymphoma In The Rituximab Era: A Retrospective Study Of The Lymphoma Working Party (LWP) Of The European Group For Blood and Marrow Transplantation (EBMT)

Syed Ahmed, MRCP, FRCPath, Ariane Boumendil, PhD, Herve Finel, Anna Sureda, MD, PhD, Harry C. Schouten, MD, PhD, Mohamad Mohty, MD PhD, Guustaaf van Imhoff, Wilfried Schroyens, MD, PhD, Jurgen Finke, Nicolaas PM Schaap, MD, PhD, Ignazio Majolino, Prof, Mario Bargetzi, MD, Enrico Maria Pogliani, MD, Boris Afanasyev, Peter Dreger, MD, Mahmoud D. Aljurf, MD

Blood (2013) 122 (21): 3368.

https://doi.org/10.1182/blood.V122.21.3368.3368

Published: 2013

Journal Articles

Incorporating High-Dose IV Methotrexate Into Initial Therapy Results In Lower Rates Of Central Nervous System (CNS) Relapse In Patients With High-Risk Diffuse Large B-Cell Lymphoma (DLBCL)

Chan Y Cheah, MBBS, FRACP, FRCPA, Kirsten Herbert, MD, BSci(Med), FRACP, PhD, Kacey O'Rourke, MBBS FRACP FRCPA, Glen Kennedy, MBBS FRACP FRCPA, Anupkumar George, MBBS FRACP FRCPA, Pasquale Fedele, MBBS, Shuh Ying Tan, MBBS, Stephen Opat, MBBS(Hons) FRACP FRCPA, Kate Burbury, MBBS, FRACP, FRCPA, DPhil, Max Wolf, MBBS, FRACP, FRCPA, Elchanan H. Januszewicz, MBBS FRACP FRCPA, Michael J. Dickinson, MBBS, FRACP, FRCPA, David A Westerman, MBBS, FRACP, FRCPA, H. Miles Prince, MBBS, FRACP, FRCPA, MD, Dennis A Carney, MBBS FRACP FRCPA, Simon J. Harrison, MBBS MRCP (uk) MRCPath (uk) PhD, Constantine S. Tam, MBBS, FRACP, FRCPA, MD, John F Seymour, MBBS, PhD, FRACP

Blood (2013) 122 (21): 4353.

https://doi.org/10.1182/blood.V122.21.4353.4353

Published: 2013

Journal Articles

MYC Gene FISH Testing in Aggressive B-Cell Lymphomas: Atypical Rearrangements May Result in Underreporting of Positive Cases

Guoxian Sun, MD, Lya Montella, MS, Min Yang

Blood (2012) 120 (21): 1552.

https://doi.org/10.1182/blood.V120.21.1552.1552

Published: 2012

Journal Articles

Double and Triple Hit Diffuse Large B Cell Lymphomas and First Line Therapy

Michael V. Jaglal, MD, Deniz Peker, MD, Jianguo Tao, MD, PhD, Jennifer L. Cultrera, MD

Blood (2012) 120 (21): 4885.

https://doi.org/10.1182/blood.V120.21.4885.4885

Published: 2012

Journal Articles

Post-Transplantation Lymphoproliferative Disorders (PTLD) Management in Solid Organ Transplantation (SOT) Recipients

Nikolai A. Podoltsev, MD, PhD, Ivan Bustillo, MD, Xiaopan Yao, PhD, Haibei Liu, Dennis L. Cooper, MD

Blood (2011) 118 (21): 4941.

https://doi.org/10.1182/blood.V118.21.4941.4941

Published: 2011

Journal Articles

Treatment of Burkitt's Like Lymphoma: A Single Institution Case Series

Vishal Ranpura, MD, Shilpan S. Shah, MD

Blood (2011) 118 (21): 4962.

https://doi.org/10.1182/blood.V118.21.4962.4962

Published: 2011

Journal Articles

Outcome of Patients with Relapsed/Refractory AIDS-Related Lymphoma In the AIDS Malignancy Consortium (AMC) 1997–2008

Ariela Noy, MD, Ulas Darda Bayraktar, Neel Gupta, Adam M. Petrich, MD, Page Moore, Shelly Lensing for the AIDS Malignancy Consortium

Blood (2010) 116 (21): 3569.

https://doi.org/10.1182/blood.V116.21.3569.3569

Published: 2010

NARROW

B-ALL/NHL 2002 GMALL Protocol As First-Line Treatment in Patients with Double-Hit Lymphoma: Favorable Results in18 Consecutive Patients from Two Italian Institutions

The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma

Unusual presentation of Burkitt-like lymphoma with 11q aberration in an elderly patient

Infectious Complications and Mortality after Autologous Stem Cell Transplantation for Lymphomas: A Comparison Between HIV-Infected and HIV-Negative Patients

Veliparib (ABT-888), Bendamustine, and Rituximab (VBR) Is Well Tolerated and Efficacious in Patients with Lymphoma: Final Analysis of a Phase 1b Clinical Trial of VB and a Cohort Expansion of Vbr in Patients with B-Cell Lymphoma

Outcomes of Primary and Secondary Transformed B-Cell Lymphomas

Differentiating Burkitt Lymphoma from Burkitt-like Lymphoma in Pediatrics: Report from the Japanese Pediatric Leukemia/Lymphoma Study Group B-NHL03 Study

Consolidative Radioimmunotherapy after Chemoimmunotherapy in Patients with Histologic Transformation of Indolent Lymphoma

Lymphomas With MYC -Translocation Other Than Burkitt’s Have An Aggressive Presentation and Poor Response To Immunochemotherapy: Study Of 34 Cases

Rituximab Improves Overall Survival In Patients Treated With CODOX-M/IVAC For Burkitt Lymphoma (BL) and B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and BL: A Single Center Experience and Review Of The Literature

Diffuse Large B Cell Lymphoma: Role Of MYC, BCL2, BCL6 Protein Expressions and Translocations

Lenalidomide In Combination With R-ESHAP (LR-ESHAP) In Patients With Relapsed Or Refractory Diffuse Large B-Cell Lymphoma Candidates To Autologous Stem-Cell Transplantation: A Phase 1b Study From Spanish Group Geltamo

Autologous Stem Cell Transplantation For Adult Burkitt Lymphoma In The Rituximab Era: A Retrospective Study Of The Lymphoma Working Party (LWP) Of The European Group For Blood and Marrow Transplantation (EBMT)

Incorporating High-Dose IV Methotrexate Into Initial Therapy Results In Lower Rates Of Central Nervous System (CNS) Relapse In Patients With High-Risk Diffuse Large B-Cell Lymphoma (DLBCL)

MYC Gene FISH Testing in Aggressive B-Cell Lymphomas: Atypical Rearrangements May Result in Underreporting of Positive Cases

Double and Triple Hit Diffuse Large B Cell Lymphomas and First Line Therapy

Post-Transplantation Lymphoproliferative Disorders (PTLD) Management in Solid Organ Transplantation (SOT) Recipients

Treatment of Burkitt's Like Lymphoma: A Single Institution Case Series

Outcome of Patients with Relapsed/Refractory AIDS-Related Lymphoma In the AIDS Malignancy Consortium (AMC) 1997–2008

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only